Debate Ignited Over US-Funded Biological Research Programs Abroad

The recent declassification of intelligence documents and comments from former Director of National Intelligence Tulsi Gabbard have reignited discussions about US-funded biological research programs abroad. Allegations suggest a network of over 120 laboratories across more than 30 countries, some involved in dangerous pathogen research. Gabbard claims these facilities operate with limited oversight and that their existence has been intentionally concealed. She has called for expanded investigations into these programs, particularly in light of documents related to a US-supported laboratory network in Ukraine. This controversy raises significant questions about biosecurity and the transparency of international research initiatives.

By Narendra Chaudhary Jun 13, 2026, 04:29 IST

Renewed Controversy Surrounding Biological Labs

A recent declassification of intelligence documents, along with comments from former Director of National Intelligence Tulsi Gabbard, has sparked renewed discussions regarding US-funded biological research initiatives in various countries. These allegations involve over 120 laboratories situated in more than 30 nations, with accompanying images highlighting high-security biological research at the US Army Medical Research Institute of Infectious Diseases located at Fort Detrick, showcasing personnel operating within a biosafety level-4 lab.

Claims of a Global Laboratory Network

Gabbard has asserted that the US government has financed an extensive network of biological labs internationally, some of which are purported to engage in research on hazardous pathogens and gain-of-function studies with minimal oversight. She further alleged that the existence, locations, and funding of these facilities have been deliberately obscured by influential entities, and that critics of these programs are often labeled as promoting foreign agendas.

Pathogen Research Concerns

In her statements, Gabbard indicated that certain labs may have dealt with highly infectious agents such as anthrax and plague, along with other dangerous pathogens. She expressed particular concern regarding gain-of-function research, which involves altering organisms to observe changes in their transmissibility or virulence. Gabbard referenced a May 2025 executive order from the Trump administration that halted federal funding for international gain-of-function research, framing it as a necessary measure against biosecurity threats.

She also criticized political leaders, public health officials, and members of the Biden administration’s national security team for downplaying or misrepresenting the extent of US-funded biological research abroad, specifically mentioning former White House advisor Dr. Anthony Fauci.

Documents Related to Ukraine Released

In conjunction with her statements, Gabbard unveiled declassified documents outlining a US-supported laboratory network in Ukraine. These documents reportedly indicate that over 40 labs in Ukraine received support through the Department of Defense’s Biological Threat Reduction Program, with specific references to several facilities. The materials also mention prior intelligence assessments suggesting that at least one lab may have housed dangerous pathogens and could be susceptible to disruption amid the ongoing conflict between Russia and Ukraine.

Calls for Broader Investigations

Gabbard has urged intelligence agencies to broaden their efforts in collecting and analyzing information regarding overseas biological labs and their research activities. She noted that additional findings have already emerged, including reports of clinical trials at certain locations. Gabbard emphasized that US intelligence agencies would persist in collaborating with partner organizations to identify laboratories, evaluate their contents, and assess any involvement in gain-of-function research. A former congresswoman from Hawaii and an Iraq War veteran, Gabbard was appointed as Director of National Intelligence in 2025 but announced her resignation in May, citing her husband's health issues, and is expected to vacate her position later this month.